Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma.

Tang F, Min L, Seebacher NA, Li X, Zhou Y, Hornicek FJ, Wei Y, Tu C, Duan Z
J Orthop Res. 2019 Mar;37(3):789-798. doi: 10.1002/jor.24227. Epub 2019 Feb 12. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.